CoChat

Cancer-associated fibroblasts: from basic science to anticancer therapy

Open access
Yang, Dakai, Liu, Jing, Qian, Hui, Zhuang, Qin · 2023 · Experimental & Molecular Medicine

The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.

Abstract

Cancer-associated fibroblasts (CAFs), as a central component of the tumor microenvironment in primary and metastatic tumors, profoundly influence the behavior of cancer cells and are involved in cancer progression through extensive interactions with cancer cells and other stromal cells. Furthermore, the innate versatility and plasticity of CAFs allow their education by cancer cells, resulting in dynamic alterations in stromal fibroblast populations in a context-dependent manner, which highlights the importance of precise assessment of CAF phenotypical and functional heterogeneity. In this review, we summarize the proposed origins and heterogeneity of CAFs as well as the molecular mechanisms regulating the diversity of CAF subpopulations. We also discuss current strategies to selectively target tumor-promoting CAFs, providing insights and perspectives for future research and clinical studies involving stromal targeting.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s12276-023-01013-0

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Cancer-associated fibroblasts (CAFs) are a heterogeneous and plastic population within the tumor microenvironment. The heterogeneity of fibroblasts could be attributed to the multiple origins of the precursor cells, the phenotypical diversity of subsets and the distinct function of each subset. Potential cellular sources include local tissue resident stellate cells and normal fibroblasts and nonfibroblast lineage or recruited bone marrow-derived mesenchymal stem cells (MSCs) and macrophages. The main subsets of CAFs include myCAFs, iCAFs and apCAFs, which exhibit different biological features and result in phenotypical diversity and functional heterogeneity in cancer progression. However, the distinct subsets of CAFs are not permanent but interconvertible via manipulation of specific signaling, as shown by the conversion between iCAFs and myCAFs via the TGFβ or IL-6 signaling pathway of CAFs. myCAFs: myofibroblast-like CAFs; iCAFs: inflammatory CAFs; apCAFs: antigen-presenting CAFs.
Fig. 1 Cancer-associated fibroblasts (CAFs) are a heterogeneous and plastic population within the tumor microenvironment. The heterogeneity of fibroblasts could be attributed to the multiple origins of the precursor cells, the phenotypical diversity of subsets and the distinct function of each subset. Potential cellular sources include local tissue resident stellate cells and normal fibroblasts and nonfibroblast lineage or recruited bone marrow-derived mesenchymal stem cells (MSCs) and macrophages. The main subsets of CAFs include myCAFs, iCAFs and apCAFs, which exhibit different biological features and result in phenotypical diversity and functional heterogeneity in cancer progression. However, the distinct subsets of CAFs are not permanent but interconvertible via manipulation of specific signaling, as shown by the conversion between iCAFs and myCAFs via the TGFβ or IL-6 signaling pathway of CAFs. myCAFs: myofibroblast-like CAFs; iCAFs: inflammatory CAFs; apCAFs: antigen-presenting CAFs.CC BY · PubMed Central
Fig. 2 The molecular mechanisms regulating CAF heterogeneity. The diversity of CAF subtypes is regulated by complex molecular mechanisms, including genetic regulation mediated by tumor cell-derived factors, epigenetic modulation via direct contact between tumor cells and CAFs, and metabolic reprogramming reflecting the reverse Warburg effect. Moreover, these mechanisms can work independently or cooperatively to shape the stromal structure and function, resulting in tumor restraining or tumor supportive effects of CAF subsets in a context-dependent manner. SOCS1: Suppressor of cytokine signaling; STAT3: Signal transducer and activator of transcription 3; LDH: Lactate dehydrogenase; PYCR1: pyrroline-5-carboxylate reductase 1.
Fig. 2 The molecular mechanisms regulating CAF heterogeneity. The diversity of CAF subtypes is regulated by complex molecular mechanisms, including genetic regulation mediated by tumor cell-derived factors, epigenetic modulation via direct contact between tumor cells and CAFs, and metabolic reprogramming reflecting the reverse Warburg effect. Moreover, these mechanisms can work independently or cooperatively to shape the stromal structure and function, resulting in tumor restraining or tumor supportive effects of CAF subsets in a context-dependent manner. SOCS1: Suppressor of cytokine signaling; STAT3: Signal transducer and activator of transcription 3; LDH: Lactate dehydrogenase; PYCR1: pyrroline-5-carboxylate reductase 1.CC BY · PubMed Central
Fig. 3 Therapeutic strategies of stroma re-engineering. Current strategies to selectively target tumor-promoting CAFs include (a) blocking the differentiation from precursor cells to tumor-promoting CAFs via inhibition of precursor activation or targeting key signaling pathways in differentiation. b Targeted depletion of tumor-promoting CAFs without affecting tumor-restraining CAFs through genetic manipulation or specific antibodies. c Induction of phenotypic switching from tumor-promoting to tumor-restraining CAFs. d Targeting the crosstalk between cancer cells and tumor-promoting CAFs to inhibit their supportive effect on cancer proliferation, migration and chemoresistance.
Fig. 3 Therapeutic strategies of stroma re-engineering. Current strategies to selectively target tumor-promoting CAFs include (a) blocking the differentiation from precursor cells to tumor-promoting CAFs via inhibition of precursor activation or targeting key signaling pathways in differentiation. b Targeted depletion of tumor-promoting CAFs without affecting tumor-restraining CAFs through genetic manipulation or specific antibodies. c Induction of phenotypic switching from tumor-promoting to tumor-restraining CAFs. d Targeting the crosstalk between cancer cells and tumor-promoting CAFs to inhibit their supportive effect on cancer proliferation, migration and chemoresistance.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 107 references

Cited by

See all 572

Metadata

Authors
Yang, D., Liu, J., Qian, H., & Zhuang, Q.
Affiliations
  • Jiangsu University (CN)
  • Shanghai University of Medicine and Health Sciences (CN)
  • Affiliated Hospital of Jiangsu University (CN)
Corresponding author
  • Yang, Dakai
  • Qian, Hui
  • Zhuang, Qin
Venue
Experimental & Molecular Medicine
Published
2023-07-03
Volume
55
Issue
7
Pages
1322-1332
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W4382895062
Cited by
572
References
107
Citations by year
2026: 208 · 2025: 229 · 2024: 123 · 2023: 12
FWCI
18.61
Type
journal article
Language
en
Open access
Licence
Locations
  • Experimental & Molecular Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (82100666)
  • Basic Research Program of Jiangsu Province (BK20200906)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords
cancer-associated fibroblasts, tumor microenvironment, CAF heterogeneity, CAF origin, stromal fibroblasts, CAF subpopulations, CAF-targeted therapy, stromal targeting, tumor progression, metastasis
MeSH terms
Cancer-Associated Fibroblasts, Fibroblasts, Humans, Neoplasms, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer-associated fibroblasts: from basic science to anticancer therapy. https://app.cochat.ai/papers/10.1038/s12276-023-01013-0
The paper
Yang, D., Liu, J., Qian, H., & Zhuang, Q. (2023). Cancer-associated fibroblasts: from basic science to anticancer therapy. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-023-01013-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.